Medpace (MEDP) is Initiated by Robert W. Baird to Neutral, Price Target at $35

Medpace (MEDP) was Initiated by Robert W. Baird to “Neutral” and the brokerage firm has set the Price Target at $35. Robert W. Baird advised their investors in a research report released on Sep 6, 2016.

In a different news, on Aug 19, 2016, August J. Troendle (CEO) purchased 10,000 shares at $27.98 per share price. According to the SEC, on Aug 18, 2016, Susan E Burwig (Sr. Vice President, Operations) purchased 19,211 shares at $29.25 per share price.

Medpace

Leave a Reply

Medpace - Is it time to Sell?

Top Brokerage Firms are advising their investors on Medpace. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.